Current Medical Research and Opinion, Volume 29, Issue 1 (2013)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Current Medical Research and Opinion, Volume 29, Issue 1 (2013)

See all volumes and issues
Vol 40, 2024 Vol 39, 2023 Vol 38, 2022 Vol 37, 2021 Vol 36, 2020 Vol 35, 2019 Vol 34, 2018 Vol 33, 2017 Vol 32, 2016 Vol 31, 2015 Vol 30, 2014 Volume 29, 2013 Vol 28, 2012 Vol 27, 2011 Vol 26, 2010 Vol 25, 2009 Vol 24, 2008 Vol 23, 2007 Vol 22, 2006 Vol 21, 2005 Vol 20, 2004 Vol 19, 2003 Vol 18, 2002 Vol 17, 2001 Vol 16, 2000 Vol 15, 1999 Vol 14, 1997-1998 Vol 13, 1992-1997 Vol 12, 1990-1992 Vol 11, 1988-1990 Vol 10, 1986-1988 Vol 9, 1984-1985 Vol 8, 1982-1984 Vol 7, 1980-1982 Vol 6, 1979-1980 Vol 5, 1977-1979 Vol 4, 1976-1977 Vol 3, 1975-1976 Vol 2, 1974-1975 Vol 1, 1972-1973
Download citations Download PDFs Download issue

Infectious Disease: Review

Review Article
Update on rifampin, rifabutin, and rifapentine drug interactions
Anne M. Baciewicz, Cary R. Chrisman, Christopher K. Finch & Timothy H. Self
Pages: 1-12
Published online: 30 Nov 2012
AbstractforUpdate on rifampin, rifabutin, and rifapentine drug interactions | Full Text | References | PDF (171.3 KB)
  • 3969 Views
  • 124 CrossRef citations
  • 0Altmetric

Neurology: Original articles

Article
Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study
Yuichi Inoue, Koichi Hirata, Naohisa Uchimura, Kenji Kuroda, Nobutaka Hattori & Masahiro Takeuchi
Pages: 13-21
Published online: 30 Nov 2012
AbstractforGabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study | Full Text | References | PDF (233.9 KB)
  • 298 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson’s disease
François Viallet, Séverine Pitel, Sylvie Lancrenon & Olivier Blin
Pages: 23-31
Published online: 04 Dec 2012
AbstractforEvaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson’s disease | Full Text | References | PDF (238.8 KB)
  • 2163 Views
  • 17 CrossRef citations
  • 0Altmetric

Cardiology: Original article

Article
Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice
Wilfried Dänschel, Elisabeth Steinhagen-Thiessen, Claudia Buffleben, David Pittrow & Steven K. Hildemann
Pages: 33-40
Published online: 30 Nov 2012
AbstractforDeterminants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice | Full Text | References | PDF (374.8 KB)
  • 193 Views
  • 1 CrossRef citations
  • 0Altmetric

Cardiology: Review

Review Article
Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)
Ludwin Ley & Helmut Schumacher
Pages: 41-53
Published online: 06 Dec 2012
AbstractforTelmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients) | Full Text | References | PDF (177.7 KB)
  • 493 Views
  • 6 CrossRef citations
  • 0Altmetric

Diabetes: Original article

Article
Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome
Charles J. Glueck, Naila Goldenberg, Joel Pranikoff, Zia Khan, Jagjit Padda & Ping Wang
Pages: 55-62
Published online: 12 Dec 2012
AbstractforEffects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome | Full Text | References | PDF (171.2 KB)
  • 843 Views
  • 27 CrossRef citations
  • 0Altmetric

Rare Diseases: Original articles

Article
THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis
Teresa Coelho, Mathew S. Maurer & Ole B. Suhr
Pages: 63-76
Published online: 13 Dec 2012
AbstractforTHAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis | Full Text | References | PDF (696 KB)
  • 3115 Views
  • 219 CrossRef citations
  • 0Altmetric
Article
The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology
Violaine Planté-Bordeneuve, Ole B. Suhr, Mathew S. Maurer, Barbara White, Donna R. Grogan & Teresa Coelho
Pages: 77-84
Published online: 13 Dec 2012
AbstractforThe Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology | Full Text | References | PDF (315 KB)
  • 1160 Views
  • 44 CrossRef citations
  • 0Altmetric

Rheumatology: Original article

Article
Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use
Wanying Li, Eric H. Sasso, Daniel Emerling, Guy Cavet & Kerri Ford
Pages: 85-92
Published online: 14 Dec 2012
AbstractforImpact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use | Full Text | References | PDF (216.2 KB)
  • 924 Views
  • 18 CrossRef citations
  • 0Altmetric

Pain: Brief report

Brief Report
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients
Sebastiano Mercadante, Claudio Adile, Riccardo Torta, Antonella Varetto, Fabio Fulfaro, Antonino Giarratano & Alessandra Casuccio
Pages: 93-97
Published online: 13 Dec 2012
AbstractforMeaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients | Full Text | References | PDF (105.7 KB)
  • 341 Views
  • 32 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Beyond disclaimers: the need for a curation-based model of PubMed
Jaime A. Teixeira da Silva et al.
Comment | Published online: 14 May 2024
Panel Interview of ONcology practices with Emergent Experience of teclistamab in the Real world: The TecPIONEER Study
Benjamin A. Derman et al.
Article | Published online: 14 May 2024
Economic burden of generalized myasthenia gravis (MG) in the United States and the impact of common comorbidities and acute MG- events
Maryia Zhdanava et al.
Article | Published online: 14 May 2024
Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice survey
Arpamas Seetasith et al.
Article | Published online: 13 May 2024
Open Access
View all latest articles